Peter E. Grebow
Gründer bei P. E. Grebow Consulting, Inc.
Profil
Peter E.
Grebow is the founder of P.
E.
Grebow Consulting, Inc. founded in 2011, where he holds the title of President.
Currently, he holds the position of Director at Q Therapeutics, Inc. since 2011 and Director at MAGiQ Therapeutics, Inc. Formerly, he was Chairman at Rebus Holdings, Inc. from 2016 to 2018, Independent Director at Optimer Pharmaceuticals LLC from 2011 to 2013, Director at Complexa, Inc., Executive VP-Worldwide Technical Operations at Cephalon, Inc. in 2010, Executive Vice President-Research & Development at Eagle Pharmaceuticals, Inc., and Vice President-Drug Development at Rhone-Poulenc Rorer Pharmaceuticals, Inc. from 1990 to 1990.
Dr. Grebow's education history includes a graduate degree from Rutgers State University of New Jersey, an undergraduate degree from Cornell University, and a doctorate degree from the University of California, Santa Barbara, conferred in 1973.
Aktive Positionen von Peter E. Grebow
| Unternehmen | Position | Beginn |
|---|---|---|
Q Therapeutics, Inc.
 Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Direktor/Vorstandsmitglied | 06.12.2011 |
| P. E. Grebow Consulting, Inc. | Gründer | 01.01.2011 |
MAGiQ Therapeutics, Inc.
 MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Peter E. Grebow
| Unternehmen | Position | Ende |
|---|---|---|
| REBUS HOLDINGS, INC. | Vorsitzender | 09.02.2018 |
Optimer Pharmaceuticals LLC
 Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Direktor/Vorstandsmitglied | 24.10.2013 |
Cephalon, Inc.
 Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Corporate Officer/Principal | 01.04.2010 |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | Corporate Officer/Principal | 01.01.1990 |
| EAGLE PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Peter E. Grebow
| Rutgers State University of New Jersey | Graduate Degree |
| Cornell University | Undergraduate Degree |
| University of California, Santa Barbara | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| EAGLE PHARMACEUTICALS, INC. | Health Technology |
| REBUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 7 |
|---|---|
Cephalon, Inc.
Cephalon, Inc. Pharmaceuticals: MajorHealth Technology Cephalon, Inc. manufactures and distributes pharmaceutical products. It engages in the discovery and development of medicines for central nervous system disorders, pain, and cancer. The company was founded on August 24, 1987 by Frank Baldino, Jr. and is headquartered in Frazer, PA. | Health Technology |
Q Therapeutics, Inc.
Q Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Q Therapeutics, Inc. engages in developing adult stem cell therapies to treat debilitating disease of the central nervous system. Its product, Q-Cells will undergo first-in-human trials for ALS. The firm’s therapeutic strategy is intended to restore the normal activity of neurons by providing the support functions present in healthy central nervous system tissue. The company was founded by Dennis B. Farrar, Mahendra S. Rao, Mani Ramaswami, and Steven Goldman in March 2002 and is headquartered in Salt Lake City, UT. | Health Technology |
Optimer Pharmaceuticals LLC
Optimer Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Optimer Pharmaceuticals LLC operates as a biopharmaceutical company. It is focused on discovering, developing, and commercializing innovative hospital specialty products. Optimer Pharmaceuticals primarily concentrates on developing DIFICID and other fidaxomicin products. The company was founded by Michael N. Chang in 1998 and is headquartered in Jersey City, NJ. | Health Technology |
| Rhone-Poulenc Rorer Pharmaceuticals, Inc. | |
Complexa, Inc.
 Complexa, Inc. Pharmaceuticals: MajorHealth Technology Complexa, Inc. operates as a biopharmaceutical company which engages on discovering and developing therapies for the treatment of severe and life-threatening fibrosis and inflammatory diseases. The firm focuses on two therapeutic areas: focal segmental glomerulosclerosis (FSGS) and pulmonary arterial hypertension (PAH), two rare diseases that can compromise the normal function of the kidney and the heart. The company was founded by Bruce A. Freeman, Raymond A. Miller, and Margaret M. Tarpey in 2008 and is headquartered in Berwyn, PA. | Health Technology |
MAGiQ Therapeutics, Inc.
MAGiQ Therapeutics, Inc. BiotechnologyHealth Technology MAGiQ Therapeutics, Inc. develops biotechnologies and therapeutics. | Health Technology |
| P. E. Grebow Consulting, Inc. |
